Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Iceland Health Focus.
A Grand Illusion: America’s Anti-China Arctic Policy Is Rooted in Paranoia and Political Bias, Not Strategic Reality
Back to Publications Drift ice camp in the middle of the Arctic Ocean as seen from the deck of the Chinese research icebreaker Xue Long. Photo: Timo Palo The Arctic Institute China Series 2025 America has long prided itself on being the guardian...
Nasdaq Reports Third Quarter 2025 Results; Surpassing $1 Billion in Solutions Quarterly Revenue and $3 Billion in ARR
NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the third quarter of 2025. Third quarter 2025 net revenue1 was $1.3 billion, an increase of 15% over the third quarter of 2024, or up 11%...
Category Intelligence Clinical Trials Market is Projected to Reach USD 106.78 Billion by 2032 | CAGR of 7.1%
CA, UNITED STATES, January 24, 2025 /EINPresswire.com/ -- The clinical trials market is experiencing steady growth, driven by rising demand for innovative therapies across therapeutic areas such as oncology, cardiology, neurology, and infectious...
VIVUS Shares Progress on Pipeline and Key Program Milestones During the 43rd Annual J.P. Morgan Healthcare Conference 2025
CAMPBELL, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs,...
Helvetic Clinics Strengthens Its Leadership in Dental Tourism in Hungary in 2024
Helvetic Clinics, recognized the best dental clinic in Hungary, continues to set the benchmark for excellence in patient care with a strategic expansion in 2024 BUDAPEST, BUDAPEST, HUNGARY, December 11, 2024 /EINPresswire.com/ -- Helvetic...
Red Cross Field Hospital in Rafah, Gaza Strip: Facts & Figures December 2024
A Red Cross and Red Crescent response The Red Cross Field Hospital is implemented in coordination with the Palestine Red Crescent Society and supported by Red Cross Societies of Australia, Austria, Canada, China (Hong Kong branch), Denmark,...
Owner: The International Committee of the Red Cross (Non-profit)
Alvotech Announces Marketing Approval in Japan of Three New Biosimilars
REYKJAVIK, Iceland, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that its commercialization...
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
REYKJAVIK, Iceland and LONDON, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Advanz Pharma, a UK...
Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy
Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Oculis will launch the PIONEER Program, which includes multiple...
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
REYKJAVIK, Iceland, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in Citi’s...
Oculis to Present at the Stifel 2024 Healthcare Conference
ZUG, Switzerland, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be present at...
'SELLING SUPERMAN' PREMIERES DIGITALLY NOV 18, A HEARTFELT TALE OF COMIC LEGACY, FAMILY, MENTAL HEALTH, AND REDEMPTION
Comic Book Fans and Documentary Lovers Get the Ultimate Gift This Fall LOS ANGELES, CA, UNITED STATES, November 14, 2024 /EINPresswire.com/ -- On November 18, the highly anticipated four-part documentary series, SELLING SUPERMAN, will be...
Oculis Announces Presentation of Phase 2 ACUITY trial results with Privosegtor in Acute Optic Neuritis at ECTRIMS
ZUG, Switzerland, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical...
Costco Wholesale Corporation Announces Quarterly Cash Dividend
ISSAQUAH, Wash., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Costco Wholesale Corporation (“Costco” or the “Company”) (Nasdaq: COST) today announced that its Board of Directors has declared a quarterly cash dividend on Costco common stock of $1.30 per...
Diabetic Retinopathy Market to Reach USD 17.82 Billion by 2034 as Diabetes Cases and Aging Population Rise
Ottawa, Sept. 17, 2025 (GLOBE NEWSWIRE) -- According to a study released by Towards Healthcare, a sister firm of Precedence Research, the diabetic retinopathy market was valued at USD 9.52 billion in 2024 and is anticipated to witness steady...
Tilde enters the global AI race with a European multilingual model and safeguards against disinformation
Latvian AI company Tilde has unveiled TildeOpen LLM, an open-source large language model trained on Europe’s flagship supercomputer LUMI. RīGA, LATVIA, October 16, 2025 /EINPresswire.com/ -- With 30 billion parameters, TildeOpen outperforms...
Axelyf Closes Seed Financing to Advance Next-Generation RNA-LNP Therapeutics
Icelandic venture capital firm Brunnur Ventures leads funding round to support development of breakthrough lipid nanoparticle delivery technologies BROOKLINE, MA, UNITED STATES, August 19, 2025 /EINPresswire.com/ -- Axelyf, Inc., a biotechnology...
Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring
Company expects early 2026 rollout in EEA; physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-driven clinical workflows BERKELEY, Calif, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”)...
PureCycle Receives REACH Certification, Unlocking EU Sales of PureFive™ Resin
ORLANDO, Fla., Oct. 14, 2025 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT), announced today it has received the REACH Certificate of Compliance, allowing the company to sell PureFive™ resin to customers in the European Union. The...
Oculis and EURETINA Announce the Winner of the Ramin Tadayoni Award 2025
ZUG, Switzerland, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations for ophthalmic and neuro-ophthalmic diseases with significant unmet medical...